•🧬GLP-1SG for research use only:
Procure a highly stable synthetic reference standard engineered for comparative incretin-mimetic pathway tracking. This specialized single-sequence compound layout coordinates precise technical parameters, helping academic laboratories evaluate functional binding configurations and downstream signaling mechanisms without baseline variability across assay protocols.
•📋1. Preclinical Handling & Solutions
Advanced solid-phase peptide synthesis guarantees exceptional batch uniformity and structural integrity across every unique lot number. To defend the core molecular chains from early sequence cleavage or degradation, preserve the dry lyophilized powder tightly sealed inside your freezer setup at -20°C, ensuring the container remains completely clear of moisture or direct ambient light. Reconstitute the vacuum-sealed cake matrix smoothly using proper sterile solvents under clean laboratory procedures. Reconstituted fluid stock solutions require continuous climate control inside refrigerator environments at 2-8°C to secure data traceability throughout your screening assays. Secure domestic shipping routes manage rapid same-day preparation on early orders to keep the material perfectly insulated during delivery.
•📊2. Verified Sequence Specifications
| Compound Blueprint: | GLP-1SG Reference Standard Presentation |
| CAS Registry Code: | 910463-68-2 (For Strict Analytical Traceability) |
| Molecular Formula Base: | C187H291N45O59 (Corresponding to the SEMA Sequence) |
| Purity Certification: | ≥99% Pure Confirmed via Analytical UV RP-HPLC Testing |
| Physical State Profile: | Lyophilized Compact Cake Powder Matrix Presentation |
| Application Intention: | Synthesized Chemical Supplier Reagent for In-Vitro Assays Only |
•🛡️3. Research Mechanisms & Preclinical FAQ
•📋What specific pathways characterize this single-sequence SEMA reference layout?
Preclinical literature monitors this compound for its functional agonism at the glucagon-like peptide-1 receptor system. In-vitro models implement the sequence to evaluate downstream signaling thresholds, cyclic-AMP co-activation readouts, and concentration-dependent binding stability within controlled bench testing systems.
•📋How do investigators verify composition quality before assay execution?
Every reference batch connects directly to its lot-matched Certificate of Analysis (COA). Independent testing networks verify target molecular mass distributions via mass spectrometry and establish a purity baseline of at least 99 percent through reversed-phase high-performance liquid chromatography to guarantee experimental reproducibility.
99% Purity Guaranteed
Independent Lab Tested
⚠️ FDA DISCLAIMER: These products are intended strictly for laboratory research use only. They are not intended for human consumption, diagnostic, or therapeutic purposes. The statements on this website have not been evaluated by the Food and Drug Administration.
